SMTL ID : 5kj2.1

The novel p300/CBP inhibitor A-485 uncovers a unique mechanism of action to target AR in castrate resistant prostate cancer

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 6TF: N-[(4-fluorophenyl)methyl]-2-{(1R)-5-[(methylcarbamoyl)amino]-2',4'-dioxo-2,3-dihydro-3'H-spiro[indene-1,5'-[1,3]oxazolidin]-3'-yl}-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide(Non-covalent)

6TF.1: 19 residues within 4Å: Chain A: F.88, L.112, D.113, S.114, Y.128, L.132, P.153, P.154, D.159, Y.160, H.165, P.166, Q.169, K.170, I.171, P.172, R.176, L.177, W.180 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.112, A:Y.128, A:L.132, A:P.154, A:Y.160, A:Q.169, A:W.180, A:W.180 Hydrogen bonds: A:D.113, A:S.114, A:Q.169, A:Q.169 Water bridges: A:Q.169 pi-Stacking: A:Y.128, A:H.165

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 3 residues within 4Å: Chain A: Y.111, L.112, Y.160 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:L.112, A:L.112

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lasko, L.M. et al., Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature (2017)

Release Date

2017-09-27

Peptides

Histone acetyltransferase p300: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Histone acetyltransferase p300

Related Entries With Identical Sequence